Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.40 |
| ▸ | NR1H2 | P55055 | 14/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL593975 | 0.86 | NR1H2 (0.44) | NR1H2CA12CA9NR1H3GABRG2 | |
| SCHEMBL29957250 | 0.86 | NR1H2 (0.44) | NR1H2CA12CA9NR1H3GABRG2 | |
| SCHEMBL7921587 | 0.85 | CCNB2 (0.41) | NR1H2CA12CA9NR1H3GABRG2 | |
| SCHEMBL29643728 | 0.85 | NR1H2 (0.45) | NR1H2CA12CA9NR1H3GABRG2 | |
| SCHEMBL2930214 | 0.85 | NR1H2 (0.39) | NR1H2CA12CA9NR1H3GABRG2 | |
| SCHEMBL31140070 | 0.85 | CCNB2 (0.41) | NR1H2CA12CA9NR1H3GABRG2 | |
| SCHEMBL10187341 | 0.85 | NR1H2 (0.41) | NR1H2CA12CA9NR1H3GABRG2 | |
| SCHEMBL594560 | 0.85 | NR1H2 (0.45) | NR1H2CA12CA9NR1H3GABRG2 | |
| SCHEMBL29955454 | 0.85 | NR1H2 (0.39) | NR1H2CA12CA9NR1H3GABRG2 | |
| SCHEMBL29955030 | 0.84 | NR1H2 (0.46) | NR1H2CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3009436-A1 | KINASE INHIBITORS AND METHODS OF USE | Intellikine, LLC (US) | 2016-04-20 | — | — | EP | disclosed |